Navigation Links
Cardium to Present at the LifeTech Capital Miami Medical Investors Conference

SAN DIEGO, Nov. 8, 2010 /PRNewswire/ -- Cardium Therapeutics (NYSE Amex: CXM) announced today that Christopher J. Reinhard, Cardium's Chairman and Chief Executive Officer will present at the LifeTech Capital Miami Medical Investors Conference on November 12, 2010 at 2:00 p.m. Eastern.  The conference will take place at the JW Marriott Marquis in Miami.  Although this presentation will not be webcast, investors can access the Company's presentation slides now available at Cardium's website at  



About Cardium

Cardium is focused on the acquisition and strategic development of new and innovative bio-medical product opportunities and businesses that have the potential to address significant unmet medical needs and definable pathways to commercialization, partnering and other economic monetizations.  Cardium's investment portfolio includes the Tissue Repair Company and Cardium Biologics, medical technology companies primarily focused on the development of innovative therapeutic products for wound healing, bone repair, and cardiovascular indications.  In July 2009, Cardium completed the sale of its InnerCool Therapies medical device business to Royal Philips Electronics, the first asset monetization from the Company's biomedical investment portfolio.  News from Cardium is located at

Copyright 2010 Cardium Therapeutics, Inc.  All rights reserved. For Terms of Use Privacy Policy, please visit Cardium Therapeutics™ Generx® and MedPodium™ are trademarks of Cardium Therapeutics, Inc.Tissue Repair™, Gene Activated Matrix™, GAM™, Excellagen™, Excellarate™, Osteorate™, Appexium™ and Linee™ are trademarks of Tissue Repair Company. (Other trademarks belong to their respective owners)

SOURCE Cardium Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Cardium Gains Exclusive Access to Novel Polymer-Based Nitric Oxide Technology for Expansion of Wound Healing Product Portfolio
2. Cardium to Present at 10th Annual Biotech in Europe Investor Forum
3. Cardium Regains Listing Compliance With NYSE Amex
4. Cardium to Present at MDB Capital Groups 2010 Bright Lights Conference
5. Cardiums Exchange Listing Compliance Plan Accepted by NYSE AMEX
6. Cardium Reports on Third Quarter 2009 Financial Results and Recent Developments
7. Cardium Announces Plans to File FDA 510(k) Application for U.S. Marketing Clearance of ExcellagenXL(TM) Gel for Diabetic, Pressure and Venous Ulcers and Other Topical Wounds
8. Cardium Completes $6.0 Million Registered Direct Offering
9. Cardium Announces New Orthobiologics Product Initiative Extending Gene Activated Matrix Technology to Deliver Bone Growth Factors
10. Cardium Provides Update on Phase 2b Excellarate Clinical Study and Plans for Additional Tissue Repair Applications
11. Cardium Regains Listing Compliance with NYSE Amex
Post Your Comments:
(Date:10/9/2015)... ANNAPOLIS, Md. , Oct. 9, 2015 ... entered into the Congressional Record her statement recognizing the ... celebrated October 11-17. IPAW is sponsored by the ... companies, and is designed to:   , Raise ... contributions of plasma donors in saving and improving lives ...
(Date:10/9/2015)... and ROCKVILLE, Md. , Oct. ... privately-held biotechnology company developing next generation vaccines based ... has entered into an exclusive worldwide licensing agreement ... the treatment or prevention of any and all ... agreement, Immunomic Therapeutics will receive an upfront payment ...
(Date:10/9/2015)... Inc., (NASDAQ: PULM ) will be webcasting the Company,s ... th Annual BIO Investor Forum on Tuesday, October 20, ... --> th Annual BIO Investor Forum on Tuesday, ... --> Pulmatrix will be presenting at the ... October 15, 2015 at 8:30 am EDT. Additionally, the Company ...
(Date:10/9/2015)... ... 09, 2015 , ... Leading microbial genomics startup uBiome today launched the first-ever ... between weight management and the microbiome. The study uses the ResearchKit framework, designed by ... app. , The uBiome app is available as a free download from the App ...
Breaking Biology Technology:
(Date:9/30/2015)... , Sept. 30, 2015  The U.S. Court ... issued another key ruling in favor of Crossmatch ... Korean fingerprint scanner company Suprema and its U.S. partner ... 1930, a trade provision that declares it unlawful to ... by infringing two of Crossmatch,s patents, the 5,900,993 patent ...
(Date:9/29/2015)... , Sept. 29, 2015  iDAvatars is excited to be ... its product to market. The official announcement was recently made ... event in San Francisco , where ... powered by IBM Watson. "It is both an ... 100 companies to bring to market the cognitive power of ...
(Date:9/28/2015)... The global image sensors ... billion by 2020, growing at a CAGR of 4.6% ... Illumination (BSI) technique to improve picture quality are expected ...      (Logo: , The light ... loss and, thus, reduce the noise interference and increase ...
Breaking Biology News(10 mins):